Searchable abstracts of presentations at key conferences on calcified tissues

ba0002op12 | (1) | ICCBH2013

The bone/vessels interplay in teenagers with chronic kidney disease

Bacchetta Justine , Doyon Anke , Vershelde Sophie , Vilayphiou Nicolas , Chapurlat Roland , Ranchin Bruno

Background: Bone fragility and vascular calcifications are to the two main morbidities of the mineral and bone disorders associated with chronic kidney disease (CKD), resulting from a combination of abnormalities such as impaired GH axis, vitamin D deficiency, hyperparathyroidism, increased FGF23 levels, hypogonadism, denutrition and drug toxicity.Methods: In a single-centre ancillary study of the longitudinal prospective European 4C study (Cardiovascula...

ba0001oc4.6 | Osteoblasts and osteocytes | ECTS2013

Periostin synergizes with osteocytes β-catenin to mediate the adaptive skeletal response to loading

Bonnet Nicolas , Ferrari Serge

Mechanical stimulation triggers periostin (Postn) expression in the periosteum and osteocytes (Oc), which downregulates Sost and activates β-catenin signaling. Hence the cortical bone response to loading is abolished in Postn−/− mice. Here we investigated the role of Oc β-catenin and its interaction with Postn on the bone biomechanical response. Postn−/− were bred with Oc-Ctnn−/− mice to generate Po...

ba0001oc2.4 | Bone quality and fracture repair - animal models | ECTS2013

PPARβ deficiency induces muscle and bone loss with aging but does not impair the bone biomechanical response to loading: a sarco-osteopenic mouse model

Bonnet Nicolas , Desvergne Beatrice , Ferrari Serge

Pparβ is crucial for muscle fatty acid oxidation. Pparβ−/− mice have reduced muscle strength, exercise performance, and also a decreased skeletal response to exercise. Here we investigate the influence of Pparβ on muscle and bone loss with aging, and its role on the bone biomechanical response to loading. Pparβ−/− and Pparβ+/+ mice were monitored at 1, 3 and 18...

ba0003oc5.6 | Important pathways in bone biology and cancer | ECTS2014

Enhanced load adaptation in long bone of cathepsin K-deficient mice

Bonnet Nicolas , Duong Lee , Ferrari Serge

Gene deletion or treatments with a cathepsin K (CatK) inhibitor in mature preclinical models result not only result in lower bone resorption but also in higher bone formation (BF) on both remodeling and modeling surfaces. Although increased production of clastokines and matrix-derived growth factors may explain the increased BF at remodeling surfaces, the mechanisms for greater BF at modeling surfaces, including the periosteum, remain unexplained. We hypothesized that the abse...

ba0005oc4.4 | Catabolism and metabolism | ECTS2016

Osteocyte-specific ablation of Pparγ improves energy metabolism and prevents fat accumulation but not bone loss in response to a high fat diet

Brun Julia , Ferrari Serge , Bonnet Nicolas

Pparγ is a master transcriptional regulator of energy metabolism. We demonstrated that Dmp1-Cre/Lox-mice (KO) have increased bone mass and improved energy metabolism. Here we investigated if Pparγ-deficiency in Dmp1 cells can prevent high fat diet effects on these parameters. For this purpose, WT and KO male mice aged of 16 weeks received a high fat or chow diet (HF 60% vs CD 10% of fat) for 12 weeks. Lean and fat, bone structure, metabolic rate and tissue temperatur...

ba0005p440 | Other diseases of bone and mineral metabolism | ECTS2016

Mice lacking periostin are resistant to bone microstructural alterations during lactation

Bonnet Nicolas , Brun Julia , Ferrari Serge

Periostin is a matricellular protein expressed in late osteoblasts/osteocytes, which levels increase in response to PTH and mechanical loading. In turn periostin contributes to modeling based bone formation while restraining bone remodeling. Periostin is also a substrate of cathepsin K and inhibition of periostin blunts the effects of cathepsin K inhibition on bone. Considering the important role of osteocytes and their cathepsin K expression on osteolysis during lactation, we...

ba0003pp16 | Bone biomechanics and quality | ECTS2014

Inhibition of RANKL-mediated bone remodeling decreases bone damage and improves strength in response to fatigue loading

Bonnet Nicolas , Gerbaix Maude , Kostenuik Paul , Ominsky Mike , Ferrari Serge

Antiresorptives consistently improve bone mass and structural strength in normally- and under-loaded bones, but concerns have been raised regarding potential effects on skeletal adaptation to fatigue loading, including damage accumulation and atypical fractures. We thus inhibited or activated osteoclasts with OPG-Fc or RANKL treatment, respectively, and evaluated bone damage and strength after fatigue in the early and later phases of repair. Adult male mice were treated with R...

ba0001pp35 | Bone biomechanics and quality | ECTS2013

The effect of fluoride on the DEXA score and material properties of ex vivo emu tibiae

Omelon Sidney , Nhan Kevin , Reid-Schachter Gillian , Lacroix Nicolas , Miles-Rossouw Malaika , Variola Fabio

Bone is a tough composite material, comprised of a compliant collageneous matrix, brittle apatite mineral crystals and a suite of non-collageneous proteins (NCPs). Bone material properties depend on these components, and their interactions at the mineral-collagen interface. ‘Bone mineral density’ (BMD), a parameter used to predict fracture risk, is routinely quantified by DEXA. Previous studies used ex vivo emu tibiae as a model to test the effect of organic...

ba0001pp432 | Osteoporosis: treatment | ECTS2013

Effects of a mutated sclerostin peptide on bone and lean mass in mice

Gerbaix Maude , Pierroz Dominique , Bonnet Nicolas , Boschert Verena , Mueller Thomas , Ferrari Serge

Sclerostin, a product of osteocytes, is known to inhibit Wnt signaling by binding the LRP5/6 receptor.We investigated the effects of a mutated mouse sclerostin protein (muScl, R118A/R144A) with potential sclerostin antagonistic activity. In vitro, muScl fully competed with wild type sclerostin for binding to LRP6, whereas its IC50 for Wnt3a activity was 4× higher than sclerostin (i.e. 600 nM). Moreover, serum osteocalcin increased in mice a...